There is enormous exuberance about starting GLP-1 drugs, but not nearly enough attention to what happens when people stop, said senior author Ziyad Al-Aly, M.D., a clinical epidemiologist at Washington University School of Medicine and chief of the Research and Development Service at the VA St
Standard drug panels use antibody-based immunoassays looking for controlled substance metabolites
Always consult your healthcare provider before starting treatment
Tofu, tempeh, or edamame: Good alternatives if meat is unappealing
Q&A: Patient trust required before AI-aided remote interventions can be implemented Much has been written about the potential of artificial intelligence-aided remote interventions to help cardiologists improve patient care, but potential drawbacks and practical issues all must be considered
A year ago, the American Academy of Ophthalmology recommended that patients experiencing vision problems while taking semaglutide stop using the drug and consult a physician